United Kingdom
United Kingdom
The UK is the largest donor to IFFIm and a leading supporter of Gavi. As of 2021, the UK’s existing core Gavi IFFIm commitments total £2.6 billion over 23 years to support Gavi core immunisation programmes and COVID-19 vaccines provided by the COVAX Facility.
The UK has made three legally binding pledges to IFFIm since its inception. The first was in 2006 for £1.38 billion and payable over 20 years from 2007-2026. In 2009, the UK pledged an additional £250 million payable over 20 years from 2010-2029. The third pledge, made to IFFIm in June 2022, extended the UK’s commitment with an additional pledge of £461 million.
In 2020, the UK pledged an additional £500 million to IFFIm for the COVAX AMC.
In its 2021 annual review, the UK Foreign, Commonwealth & Development Office (FCDO) gave IFFIm a score of A+. The report noted, “IFFIm plays a critical role in Gavi’s financial strategy as a source of long-term, predictable and flexible funding for Gavi 5.0. The COVID-19 pandemic has further reinforced the importance of IFFIm’s proven frontloading model, with IFFIm emerging as an indispensable frontloading vehicle for donors to leverage in support of equitable access to COVID-19 vaccines via CEPI and the COVAX AMC.”
United Kingdom
US$ equivalent
US$ 4,230 million
*over 23 years
Currency of pledge
GBP 2,591 million
*over 23 years
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.